Strategy of FK 506 therapy in liver transplant patients: effect of graft function.
作者信息
Abu-Elmagd K M, Fung J J, Alessiani M, Jain A, Takaya S, Venkataramanan R, Warty V S, Shannon W, Todo S, Tzakis A
机构信息
Department of Surgery, University of Pittsburgh, PA 15213.
出版信息
Transplant Proc. 1991 Dec;23(6):2771-4.
Abstract
摘要
相似文献
1
Strategy of FK 506 therapy in liver transplant patients: effect of graft function.肝移植患者FK 506治疗策略：移植肝功能的影响
Transplant Proc. 1991 Dec;23(6):2771-4.
2
Treatment of steroid-resistant rejection with tacrolimus prior to OKT3 in liver transplant recipients.肝移植受者在使用OKT3之前用他克莫司治疗类固醇抵抗性排斥反应。
Transplant Proc. 1996 Apr;28(2):1014.
3
FK 506 rescue therapy: the rapidity of rejection reversal is related to the subsequent development of CMV disease.FK506挽救治疗：排斥反应逆转的速度与随后巨细胞病毒疾病的发生有关。
Transplant Proc. 1993 Apr;25(2):1992-3.
4
Plasma level-guided low-dose FK 506 therapy in patients with early liver dysfunction after liver transplantation.
Transplant Proc. 1993 Aug;25(4):2688-90.
5
FK 506 rescue therapy for resistant rejection episodes in liver transplant recipients.FK506 对肝移植受者难治性排斥反应发作的挽救治疗。
Transplant Proc. 1991 Dec;23(6):2987-8.
6
Use of FK 506 for treatment of chronic rejection after liver transplantation.使用FK 506治疗肝移植后的慢性排斥反应。
Transplant Proc. 1991 Dec;23(6):2984-6.
7
Conversion to rescue therapy with FK 506: data from eight liver transplant patients.转换为使用他克莫司（FK 506）进行挽救治疗：来自八名肝移植患者的数据。
Transplant Proc. 1994 Dec;26(6):3597-8.
8
FK 506 versus cyclosporine in pediatric liver transplantation.儿童肝移植中FK506与环孢素的比较
Transplant Proc. 1991 Dec;23(6):3010-5.
9
FK 506 treatment of intractable rejection after liver transplantation.FK506治疗肝移植后难治性排斥反应
Transplant Proc. 1993 Aug;25(4):2686-7.
10
引用本文的文献
1
Guidance on Selecting Optimal Steady-State Tacrolimus Concentrations for Continuous IV Perfusion: Insights from Physiologically Based Pharmacokinetic Modeling.基于生理药代动力学模型的见解：连续静脉灌注中选择最佳稳态他克莫司浓度的指导意见
Pharmaceuticals (Basel). 2024 Aug 8;17(8):1047. doi: 10.3390/ph17081047.
2
A Safety and Tolerability Study of Thin Film Freeze-Dried Tacrolimus for Local Pulmonary Drug Delivery in Human Subjects.人用局部肺部给药的薄膜冻干他克莫司安全性和耐受性研究
Pharmaceutics. 2021 May 13;13(5):717. doi: 10.3390/pharmaceutics13050717.
3
Evaluation of limited sampling methods for estimation of tacrolimus exposure in adult kidney transplant recipients.评估用于估算成人肾移植受者他克莫司暴露量的有限采样法。
Br J Clin Pharmacol. 2011 Feb;71(2):207-23. doi: 10.1111/j.1365-2125.2010.03815.x.
4
Pharmacokinetic considerations relating to tacrolimus dosing in the elderly.与老年人他克莫司给药相关的药代动力学考量
Drugs Aging. 2005;22(7):541-57. doi: 10.2165/00002512-200522070-00001.
5
Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.他克莫司在实体器官移植中的临床药代动力学与药效学
Clin Pharmacokinet. 2004;43(10):623-53. doi: 10.2165/00003088-200443100-00001.
6
Effects of liver disease on pharmacokinetics. An update.肝脏疾病对药代动力学的影响。最新进展。
Clin Pharmacokinet. 1999 Nov;37(5):399-431. doi: 10.2165/00003088-199937050-00004.
7
What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients.关于在他克莫司免疫抑制下进行的原位肝移植，我们了解到了什么？对首批1000例患者的长期随访。
Ann Surg. 1999 Sep;230(3):441-8; discussion 448-9. doi: 10.1097/00000658-199909000-00016.
8
Clinical pharmacokinetics of tacrolimus.他克莫司的临床药代动力学
Clin Pharmacokinet. 1995 Dec;29(6):404-30. doi: 10.2165/00003088-199529060-00003.
9
An intelligent and cost-effective computer dosing system for individualizing FK506 therapy in transplantation and autoimmune disorders.一种用于在移植和自身免疫性疾病中实现FK506治疗个体化的智能且经济高效的计算机给药系统。
J Clin Pharmacol. 1993 Jul;33(7):599-605. doi: 10.1002/j.1552-4604.1993.tb04711.x.
本文引用的文献
1
Clinical pharmacokinetics of cyclosporin.环孢素的临床药代动力学
Clin Pharmacokinet. 1986 Mar-Apr;11(2):107-32. doi: 10.2165/00003088-198611020-00002.
2
Augmentation of rat liver regeneration by FK 506 compared with cyclosporin.与环孢素相比，FK 506对大鼠肝脏再生的增强作用。
Lancet. 1989 Nov 25;2(8674):1248-9. doi: 10.1016/s0140-6736(89)91853-9.
3
A highly sensitive method to assay FK-506 levels in plasma.一种检测血浆中FK-506水平的高灵敏度方法。
Transplant Proc. 1987 Oct;19(5 Suppl 6):23-9.
4
Acute and chronic renal failure in liver transplantation.肝移植中的急性和慢性肾衰竭
Nephron. 1990;55(2):121-8. doi: 10.1159/000185938.
5
The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver.移植功能对FK506血药浓度、剂量及肾功能的影响，尤其涉及肝脏。
Transplantation. 1991 Jul;52(1):71-7. doi: 10.1097/00007890-199107000-00015.
6
7
Hepatotrophic effects of FK506 in dogs.FK506对犬的肝营养作用。
Transplantation. 1991 Jan;51(1):67-70. doi: 10.1097/00007890-199101000-00010.
8
Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations.肝功能不全和T管夹闭对FK 506药代动力学及谷浓度的影响。
Transplant Proc. 1990 Feb;22(1):57-9.
9
Pharmacokinetics of FK 506: preclinical and clinical studies.FK506的药代动力学：临床前和临床研究。
Transplant Proc. 1990 Feb;22(1):52-6.
10
The effects of FK 506 on renal function after liver transplantation.FK506对肝移植后肾功能的影响。
Transplant Proc. 1990 Feb;22(1):17-20.
Zotero 插件